Comparison of Gene-Expression of MC3T3-E1 Osteoblastic Cell Cultured on Machined Titanium Surface and Resorbable Blast Material Titanium Surface


Article Preview

Because of its high biocompatibility, hydroxyapatite(HA) has been considered as a good blasting material. DNA microarray is a new molecular technology that enables the analysis of gene expression in parallel on a very large number of genes, spanning a significant fraction of the human genome. It is a qualitive analysis (e.g. it can differentiate each single gene) and quantitative, since it has the sensitivity to detect a change of expression level in the investigated cells when compared to normal samples. The aim of this study is to define the cell attachment and the genetic effect of machined surface implant and RBM (resorbable blast media) surface implant on the osteoblastic cell (MC3T3-E1 osteoblastic cell line) by cDNA microarray slide containing 21575 genes. Cells were cultured on machined grade 4 titanium disks(Group 1, machined surface) and disks of RBM (Group 2) and the samples were moved to new dishes and media were added and the plated disks were cultured for 24 hours. Total RNA extraction was performed with Qiagen mini kit (Qiagen, Chatsworth, CA, USA) for microarray assay. Microarray assay after culturing the cells on the machined surface and RBM surface revealed that osteoinductive molecules appeared more prominent on the RBM surface, whereas the adhesion molecules on the biomaterial were higher on the machined surface than RBM surface.



Key Engineering Materials (Volumes 361-363)

Main Theme:

Edited by:

Guy Daculsi and Pierre Layrolle




S.H. Park et al., "Comparison of Gene-Expression of MC3T3-E1 Osteoblastic Cell Cultured on Machined Titanium Surface and Resorbable Blast Material Titanium Surface", Key Engineering Materials, Vols. 361-363, pp. 1095-1098, 2008

Online since:

November 2007




[1] Carlsson L, et al. Acta Orthop Scand 1986; 57(4): 285-9.

[2] Szmukler-Moncler S, et al. J Biomed Mater Res B Appl Biomater 2004; 69(1): 46-57.

[3] Anselme K, et al. J Biomed Mater Res 2002; 60(4): 529-40.

[4] Li LH, et al. Biomaterials 2004; 25(14): 2867-75.

[5] Gotfredsen K, et al. J Biomed Mater Res 1995; 29(10): 1223-31.

[6] Feighan JE, G, et al. J Bone Joint Surg Am 1995; 77(9): 1380-95.

[7] Piattelli M, et al. J Oral Implantol 2002; 28(1): 2-8.

[8] Puleo DA, et al. Biomaterials 1999; 20(23-24): 2311-21.

[9] de Jong DS, van Zoelen EJ, et al. J Bone Miner Res 2002; 17(12): 2119-29.

[10] Carinci F, et al Oral Oncol 2003; 39(1): 69-77.

[11] Niimi A, et al. Clin Oral Implants Res 1997; 8(4): 286-9.

[12] Cho SA, Park KT. Biomaterials 2003; 24(20): 3611-7.

Fetching data from Crossref.
This may take some time to load.